Wanbury completes USFDA inspection at Tanuku Plant with 5 observations

06 Mar 2018

Wanbury has completed the United States Food and Drug Administration (USFDA) inspection at its major API facility in Tanuku Plant, Andhra Pradesh with five observations. The same is being addressed and will be resolved by the Regulatory Team.  The audit was carried out for a period of 5 days and concluded on March 2, 2018.

Wanbury is a pharmaceutical company and offers active pharmaceutical ingredient (API) in over 70 countries.


Related Wanbury Ltd. Links:

Wanbury Share Price

19.70 0.25 (1.29%) Jan 17, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 454.45
Lupin 766.25
Dr. Reddys Lab 3033.65
Piramal Enterprises 1627.05
Cadila Healthcare 269.10
View more..
Sensex vs Wanbury
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463